You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The first edition of this text offers guidance and advice on the diagnosis and management of the complete spectrum of ophthalmic tumors, including the eyelid, conjunctival, intraocular, and orbital tumors. The editors are joined by over 120 international contributors to present a broad perspective from a multidisciplinary team that will offer a diverse and balanced view of ophthalmic oncology clinical practice. This is a comprehensive book that includes over 100 chapters, organized into 7 sections that provide a wealth of information for the management of patients with ophthalmic tumors from examination techniques to classification to surgical techniques.
Written by internationally renowned experts, Clinical Ophthalmic Oncology provides practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. The book supplies all of the state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible. Using the information provided, readers will be able to provide effective patient care using the latest knowledge on all aspects of ophthalmic oncology, to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs, and to locate required information quickly owing to the clinically focused and user-friendly format. In this volume, all aspects of the diagnosis, histopathology, genetics and treatment of retinoblastoma are discussed in detail.
This book highlights the unique aspects of oncologic ophthalmology as a medical and surgical discipline practiced at a comprehensive cancer center. Multi-disciplinary management of ocular, orbital and adnexal cancers are highlighted using simple and tried-and-true algorithms. In addition, ocular problems caused as a direct result of cancer treatment are reviewed using illustrative photographs and case presentations. The content is provided by full-time ophthalmology faculty and fellows at M. D. Anderson Cancer Center. Experts in complementary disciplines such as ophthalmic pathology, dermatopathology, radiation oncology, radiology, and other surgical subspecialties have brought their unique perspective to each chapter. The book is abundant with clinical photographs as well as interesting case presentations that will help the clinician correctly diagnose cancers of the orbit, eye, and adnexal structures, initiate appropriate management, as well as recognize and treat common ocular complications of cancer therapy.
Patient specific and disease specific stem cell lines have already introduced groundbreaking advances into the research and practice of ophthalmology. This volume provides a comprehensive and engaging overview of the latest innovations in the field. Twelve chapters discuss the fastest growing areas in ophthalmological stem cell research, from disease modelling, drug screening and gene targeting to clinical genetics and regenerative treatments. Innovative results from stem cell research of the past decade are pointing the way toward practicable treatments for retinitis pigmentosa, age related macular degeneration, and Stargardt disease. What future directions will stem cell research take? Researchers, graduate students, and fellows alike will find food for thought in this insightful guide tapping into the collective knowledge of leaders in the field. Stem Cells in Ophthalmology is part of the Stem Cells in Regenerative Medicine series dedicated to discussing current challenges and future directions in stem cell research.
This book provides an expert overview of all aspects of ophthalmic care in clinical practice. Areas such as External eye, Cornea and conjunctiva, Glaucoma, Cataract, Macular degeneration and Diabetic retinopathy and retinal vascular events are discussed throughout the chapters. Essentials in Ophthalmic Practice will be a go-to guide for ophthalmologists, optometrists, orthoptists, ophthalmic nurses, ophthalmic technicians and other allied health professionals in their busy day-to-day practice.
Principles and Practice of Particle Therapy Although radiation has been used therapeutically for over 100 years, the field of radiation oncology is currently in the midst of a renaissance, particularly with regards to the therapeutic use of particles. Over the past several years, access to particle therapy, whether it be proton therapy or other heavy ion therapy, has increased dramatically. Principles and Practice of Particle Therapy is a clinically oriented resource that can be referenced by both experienced clinicians and those who are just beginning their venture into particle therapy. Written by a team with significant experience in the field, topics covered include: Background informati...
Ophthalmic Surgery, edited by Drs. George Spaeth, Helen Danesh-Meyer, Ivan Goldberg, and Anselm Kampik, provides the detailed, full-color, step-by-step guidance you need to master essential ophthalmic surgery procedures. The international team of expert editors and contributors present coverage of the latest surgical developments and video demonstrations of key techniques across subspecialties, including cataract, cornea, refractive, glaucoma, oculoplastic, extra-ocular muscle, vitreoretinal, and ocular tumor procedures. What’s more, the fully searchable text, procedural videos, and a downloadable image gallery are all online at www.expertconsult.com, making this multimedia resource the ke...
This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to ta...